Publications » Search Results » 1997

 2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962
Show per page  
Conferences
41Skarda I.; Dzerve V.; Klincare D.; Vitols A.; Kalnins U.; Kalvins I. Mildronate - a new drug for treatment of chronic heart failure. XVIth Nordic congr. of cardiology; June 11-13; Vol.31, suppl.45, Eds.; Scand. Cardiovasc. J.: Tampere, Finland, 1997; 22.      

42Skarda I.; Dzerve V.; Klincare D.; Vitols A.; Kalnins A.; Dinne I.; Kalvins I. The comparison of acute and chronic dose-dependent effects of a new mildronate in the treatment of chronic heart failure. Abstr., Second Intern. meet. Heart Failure,97; May 24-27: Cologne, Germany, 1997; 83.      

43Skarda I.; Dzerve V.; Klincare D.; Vitols A.; Kalnins U.; Dinne I.; Kalvins I. Influence of long-term mildronate treatment on quality of life and hemodinamic parameters of congestive heart failure patients . Abstr. , 5th World congr. on Heart failure: Mechanisms and management; May 11-14; Washington, USA, Eds.; J. Heart Failure: Vol.4 (1), 1997; 53.      

44Lemba J.; Kramzaka I.; Liepinlauskis A.; Karklins R.; Kalvins I. Application of electrodialysis to the production of organic acid. 8th Europ. congr. on biotechnology; 17-21 Aug.: Budapest, Hungary, 1997; 258.      

45Skārda I.; Dzērve V.; Klincāre D.; Vitols A.; Kalniņš U.; Dinne I.; Meldere D.; Gailišs E.; Treiņins A.; Menis E.; Kalviņš I. Mildronāts hroniskas sirds mazspējas ārstēšanā . Tēzes, Pasaules trešais latviešu ārstu kongr.; 25.-28. jūnijs: Rīga, Latvija, 1997; 100.      

46Kauss V.; Kalvinsh I.; Shestakova I.; Grigoryeva V.; Domracheva I.; Kanepe I.; Zharkova O. Cytotoxic effect of NO donors Ad and AI-271 on the cells of different tumor lines. Abstr., 2nd Intern. congr. of the Europ. Tissue Culture Soc.; 12-15 Oct.; Mainz, Germany, Eds.; Eur. J. Cell. Biol.: Vol.74, suppl.47, 1997; 34.      

47Andrianov V.; Kalvinsh I.; Shestakova I.; Domracheva I.; Grigoryeva N.; Mezhapuke R.; Kanepe I.; Zharkova O. Distant intercellular interaction of HT-1080 cells under the effect of cytotoxic compounds. Abstr., 2nd Intern. congr. of the Europ. Tissue Culture Soc.; 12-15 Oct.; Mainz, Germany, Eds.; Eur. J. Cell. Biol.: Vol.74, suppl.47, 1997; 7.      

48Vēveris M.; Jēča G. Neuroprotective effect of cerebrocrast in rabbit model of subarachnoidal extravasation . Abstracts, International Conference Trends in neuroprotective drugs: Design, pharmacology and clinics = TNPD; May 29-June 1; Riga, Latvia, Eds.; Pharmacol. Toxicol.: Vol.80, Suppl.1, 1997; 55.      

49Rudzish R.; Chipens G.; Bobrova I. Structural similarity of HSP 65 and HSP 70 with MHC class II and group A streptococci M proteins and superantigens . Abstracts, International Conference Trends in neuroprotective drugs: Design, pharmacology and clinics = TNPD; May 29-June 1; Riga, Latvia, Eds.; Pharmacol. Toxicol.: Vol.80, Suppl.1, 1997; 45.      

50Lukevics E.; Segal I.; Zablotskaya A.; Ģērmane S. Psychotropic activity of some new tetrahydroquinoline, tetrahydroiso- and tetrahydrosilaisoquinoline derivatives. Abstracts, International Conference Trends in neuroprotective drugs: Design, pharmacology and clinics = TNPD; May 29-June 1; Riga, Latvia, Eds.; Pharmacol. Toxicol.: Vol.80, Suppl.1, 1997; 32.      

Show per page